Florida legislation · 2026 Regular Session
Florida S1752: Suicide and Drug Overdose Prevention
Status: Failed, March 13, 2026
Creating the Drug Overdose Death Review Committee and the Suicide Death Review Committee, respectively, within the Department of Health for specified purposes; providing for membership of the committees and duties of the Drug Overdose Death Review Committee and the Suicide Death Review Committee, respectively; authorizing external stakeholders to review specified information; requiring the Drug Overdose Death Review Committee and the Suicide Death Review Committee, respectively, to annually submit a report to the Department of Health and the Statewide Drug Policy Advisory Council by a specified date, etc.
What the bill says
An act relating to suicide and drug overdose prevention; creating ss. 394.47893 and 394.47894, F.S.; providing legislative intent and purpose; creating the Drug Overdose Death Review Committee and the Suicide Death Review Committee, respectively, within the Department of Health for specified purposes; requiring local public health departments to establish local review committees for a specified purpose; providing for membership of the committees and duties of the Drug Overdose Death Review Committee and the Suicide Death Review Committee, respectively…
From the introduced text, January 9, 2026:
A bill to be entitled An act relating to suicide and drug overdose prevention; creating ss. 394.47893 and 394.47894, F.S.; providing legislative intent and purpose; creating the Drug Overdose Death Review Committee and the Suicide Death Review Committee, respectively, within the Department of Health for specified purposes; requiring local public health departments to establish local review committees for a specified purpose; providing for membership of the committees and duties of the Drug Overdose Death Review Committee and the Suicide Death Review Committee, respectively; authorizing external stakeholders to review specified information; providing for stakeholder participation; requiring the Drug Overdose Death Review Committee and the Suicide Death Review Committee, respectively, to annually submit a report to the Department of Health and the Statewide Drug Policy Advisory Council by a specified date; providing requirements for the report; authorizing the chair of the committees to access certain records; authorizing the committees to access certain records and information; authorizing providers to charge a specified fee for records; providing requirements for and prohibitions on the use of such records and information; authorizing the chair of the Drug Overdose Death Review Committee and the Suicide Death Review Committee, respectively, to issue subpoenas for records; providing construction; providing that persons who attend a committee meeting or otherwise participate in committee activities may not be required to testify in …